Table 5

Subgroup analyses for all-cause mortality

OutcomesVariableGroupNumber of cohortsRRR and 95% CIP valueI2 (%)P value for heterogeneityP value for meta-regression
All-cause mortalityPublication yearBefore 201071.51 (1.23 to 1.85)<0.00138.20.138
2010 or after0
CountryWestern61.63 (1.41 to 1.88)<0.0018.20.3640.039
Eastern10.71 (0.33 to 1.55)0.394
Sample size≥10 00031.66 (1.46 to 1.90)<0.0010.00.7720.050
<10 00041.06 (0.59 to 1.90)0.84443.70.149
Assessment of DMSelf-reported21.69 (1.46 to 1.95)<0.0010.00.6690.123
Measured41.06 (0.59 to 1.90)0.84443.70.149
Both11.50 (1.03 to 2.19)0.035
Follow-up duration (years)≥1071.51 (1.23 to 1.85)<0.00138.20.138
<100
Adjusted other CVD risk factorsYes41.50 (1.12 to 2.01)0.00639.40.1760.850
No31.33 (0.75 to 2.36)0.32157.60.095
Study qualityHigh21.69 (1.41 to 2.02)<0.0010.00.4900.414
Low51.25 (0.80 to 1.94)0.32953.30.073
  • CVD, cardiovascular disease; DM, diabetes mellitus.